Heidelberg Pharma GmbH

Allemagne

Commandez votre montre hebdomadaire Heidelberg Pharma GmbH
Quantité totale PI 14
Rang # Quantité totale PI 110 810
Note d'activité PI 0,4/5.0    1
Rang # Activité PI 962 919
Parent Wilex AG

Brevets

Marques

2 0
5 0
7 0
0
 
Dernier brevet 2019 - Novel method for synthesizing am...
Premier brevet 2004 - Nucleotide lipid ester derivatives

Derniers inventions, produits et services

2018 Invention Novel method for synthesizing amanitins. The invention relates to novel methods for synthesizing ...
2017 Invention Amatoxin-conjugates with improved linkages. The present disclosure relates to tumour therapy. In...
2016 Invention Amatoxin-antibody conjugates. The invention relates to conjugates comprising amatoxins and antibo...
2014 Invention Amatoxin derivatives. The invention relates to tumor therapy. In one aspect, the present inventio...
Invention Amatoxin derivatives. The invention relates to tumour therapy. In one aspect, the present inventi...
2013 Invention Methods for synthesizing amatoxin building block and amatoxins. The invention relates to novel me...
2012 Invention Amatoxin-conjugates with improved linkages. The invention relates to tumor therapy. In one aspec...
Invention Amatoxin-conjugates with improved linkages. The invention relates to tumour therapy. In one aspec...
2011 Invention Amatoxin-conjugates with improved linkers. The invention relates to tumour therapy. In one aspect...
2006 Invention Use of fosfluridine tidoxil (ft) for the treatment of intraepithelial proliferative diseases. The...
Invention Use of ether-linked lysophosphatidylcholines and alkylphosphocholines for the treatment of papill...
Invention 7-ethyl-10-hydroxy-camptothecin lipid ester derivatives. The subject of the present invention are...
2005 Invention Parenteral forms of administration of imexon and method for the production thereof. The invention...
2004 Invention Nucleotide lipid ester derivatives. The subject of the present invention are specific lipidesters...